BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Breaking News: Best of BioWorld Science: Q1
See today's BioWorld Science
Home
» Evaxion unveils EVX-04 for acute myeloid leukemia
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Evaxion unveils EVX-04 for acute myeloid leukemia
Nov. 4, 2025
No Comments
Evaxion A/S has unveiled EVX-04, an AI-designed precision cancer vaccine candidate being developed for acute myeloid leukemia (AML).
BioWorld Science
Cancer
Immuno-oncology
Vaccine
